Sham Comparator
Sham Comparator is a medical device with 117 clinical trials. Currently 40 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 48 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
18
Mid Stage
15
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.7%
48 of 56 finished
14.3%
8 ended early
40
trials recruiting
117
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Randomized Study of an Analgesic Device Enabling Local Anesthetic Delivery and Neuromodulation After Shoulder/Foot Surgery
Evaluation of Trigeminal Nerve Blockade
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait
Clinical Trials (117)
Randomized Study of an Analgesic Device Enabling Local Anesthetic Delivery and Neuromodulation After Shoulder/Foot Surgery
Evaluation of Trigeminal Nerve Blockade
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait
Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial
Interest of Auriculotherapy in the Management of Chronic Insomnia
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Early Neuromodulation in Traumatic Brain Injury
Effect of Osteopathic Manipulation on Circulating Immune Markers
Sleep and Performance
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder
Early Life Intervention in Pediatrics Supported by E-health - SMOKE
acTBS Treatment for Inpatient Subjects With Suicidality
LINK-HF2 - Remote Monitoring Analytics in Heart Failure
Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage
Novel Mental Health Therapies to Improve Military Readiness
Transcranial Magnetic Stimulation for MCI
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 117